Identifying High-Risk Covid-19 Patients
Research suggests that measuring mitochondrial DNA could predict who will need ICU care, intubation.
Read MorePosted by Laurie Bonner | Jan 20, 2021 | Covid 19, Molecular Diagnostics |
Research suggests that measuring mitochondrial DNA could predict who will need ICU care, intubation.
Read MorePosted by Melanie Hamilton-Basich | Jan 19, 2021 | Covid 19 |
Thermo Fisher’s Intact Virus Precipitation Reagent purifies intact SARS-CoV-2 virus from large, dilute samples in only three steps and in less than three hours, while the Dynabeads Intact Virus Enrichment Kits automate virus sample purification for high-throughput enrichment in less than 20 minutes.
Read MorePosted by Melanie Hamilton-Basich | Jan 18, 2021 | Covid 19, Research |
Oxford Immunotec will perform T cell testing on participants receiving Valneva’s inactivated whole-virus covid-19 vaccine candidate with the research-use-only T-SPOT Discovery SARS-CoV-2 test.
Read MorePosted by Melanie Hamilton-Basich | Jan 15, 2021 | Covid 19, Molecular Diagnostics |
The PerkinElmer New Coronavirus Nucleic Acid Detection Kit received EUA from the FDA to test individuals without symptoms or other reasons to suspect covid-19 infection.
Read MorePosted by Melanie Hamilton-Basich | Jan 15, 2021 | Company News, Covid 19 |
Under the program, Mammoth will leverage its robust DETECTR platform for CRISPR-based diagnostics to detect emerging biological threats.
Read More